A pilot study of a novel translational research method to simultaneously assay multiple molecular markers and DNA in fine‐needle aspirates (FNA) of mammographically detected breast lesions is described. Specimen mammography‐guided 20‐gauge FNAs obtained from 86 lesions and 22 areas of normal tissue were analyzed by multiparameter flow cytometry for DNA content, her2/neu, transforming growth factor α (TGFα), and the epithelial marker cytokeratin (CK) simultaneously. Epithelial cell her2/neu positivity was detected in 12 of 44 (27%) of invasive ductal carcinomas and 3 of 9 (33%) ductal carcinoma in situ (DCIS), 10 of 30 (33%) benign lesions, and 4 of 22 (18%) normal tissue aspirates. All lesions and normal tissue showed a similar positive rate for TGFα ranging from 61 to 76%. The CK+TGFα−her2/neu+ immunophenotype was more frequently positive in aneuploid tumors (22%) than all other lesions (7%) (P < 0.05). Specimen mammography‐guided FNAs provide fresh cells for flow cytometric multiple marker analysis and immunophenotyping of clinically occult breast lesions and normal tissue. Cytometry (Comm. Clin. Cytometry) 42:165–173, 2000. © 2000 Wiley‐Liss, Inc.